We are live on ! Find out more
STSA

Satsuma Pharmaceuticals, Inc. Common Stock
STSA

Delisted

STSA was delisted on the 7th of June, 2023.

Back to rankings

30 hedge funds and large institutions have $202M invested in Satsuma Pharmaceuticals, Inc. Common Stock in 2019 Q3 according to their latest regulatory filings, with 30 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
30
Holders Change
+30
Holders Change %
–
% of All Funds
0.66%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.04%
New
30
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
RCM
RA Capital Management
Massachusetts
+$72.6M
2
Wellington Management Group
Wellington Management Group
Massachusetts
+$37.3M
3
TGHSA
TPG Group Holdings (SBS) Advisors
Texas
+$29.3M
4
Citadel Advisors
Citadel Advisors
Florida
+$14.9M
5
CC
Caxton Corporation
New Jersey
+$13.5M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
RCM
1
RA Capital Management
Massachusetts
$70.3M +$72.6M +4,681,858 New
Wellington Management Group
2
Wellington Management Group
Massachusetts
$35.8M +$37.3M +2,405,295 New
TGHSA
3
TPG Group Holdings (SBS) Advisors
Texas
$28.3M +$29.3M +1,885,939 New
Citadel Advisors
4
Citadel Advisors
Florida
$14.4M +$14.9M +958,382 New
CC
5
Caxton Corporation
New Jersey
$13.1M +$13.5M +870,820 New
CAM
6
Cormorant Asset Management
Massachusetts
$12.9M +$13.3M +858,382 New
Adage Capital Partners
7
Adage Capital Partners
Massachusetts
$9.16M +$9.46M +610,000 New
EAM
8
Eventide Asset Management
Massachusetts
$6.38M +$6.59M +425,000 New
CS
9
Credit Suisse
Switzerland
$4.63M +$4.79M +308,584 New
ZP
10
Zimmer Partners
New York
$1.5M +$1.55M +100,000 New
MIM
11
Monashee Investment Management
Massachusetts
$938K +$970K +62,500 New
BlackRock
12
BlackRock
New York
$900K +$930K +59,970 New
DIM
13
DC Investments Management
Virginia
$533K +$551K +35,502 New
Vanguard Group
14
Vanguard Group
Pennsylvania
$526K +$543K +35,000 New
Millennium Management
15
Millennium Management
New York
$525K +$544K +35,038 New
MWNA
16
Marshall Wace North America
New York
$501K +$518K +33,380 New
Goldman Sachs
17
Goldman Sachs
New York
$413K +$427K +27,500 New
Norges Bank
18
Norges Bank
Norway
$225K +$233K +15,000 New
WAM
19
Weiss Asset Management
Massachusetts
$212K +$220K +14,150 New
Teacher Retirement System of Texas
20
Teacher Retirement System of Texas
Texas
$150K +$155K +10,000 New
TAM
21
Tiverton Asset Management
Delaware
$125K +$129K +8,300 New
Northern Trust
22
Northern Trust
Illinois
$104K +$108K +6,961 New
GHCM
23
Glen Harbor Capital Management
California
$34K +$35.3K +2,278 New
MCIM
24
Meadow Creek Investment Management
Georgia
$28K +$29.1K +1,876 New
EP
25
Elkfork Partners
Oregon
$22K +$22.9K +1,474 New
1
2

STSA Hedge Fund Activity: Q3 2019 in Review

30 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Satsuma Pharmaceuticals, Inc. Common Stock (STSA) for Q3 2019, worth a combined $202M.

Buyers outnumbered sellers: 30 funds opened new STSA positions and 0 closed out — a net gain of 30 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was RA Capital Management, opening a new position worth an estimated $72.6M.

  • 30 institutional investors held Satsuma Pharmaceuticals, Inc. Common Stock (STSA) as of Q3 2019, up from 0 in Q2 2019.
  • Funds reported $202M of Satsuma Pharmaceuticals, Inc. Common Stock stock for Q3 2019.
  • 30 funds opened new Satsuma Pharmaceuticals, Inc. Common Stock positions in Q3 2019 and 0 closed out, a net change of +30 holders.
  • The largest Satsuma Pharmaceuticals, Inc. Common Stock buyer in Q3 2019 was RA Capital Management, an estimated $72.6M added.

Based on aggregated 13F filings for Q3 2019.